首页 | 本学科首页   官方微博 | 高级检索  
     

美能注射液治疗玫瑰糠疹48例临床观察
引用本文:王然,蔡宏为,董琛. 美能注射液治疗玫瑰糠疹48例临床观察[J]. 广东药学院学报, 2006, 22(1): 105-106
作者姓名:王然  蔡宏为  董琛
作者单位:中山大学附属第五医院,皮肤科,广东,珠海,519000;中山大学附属第五医院,皮肤科,广东,珠海,519000;中山大学附属第五医院,皮肤科,广东,珠海,519000
摘    要:
目的观察美能注射液治疗玫瑰糠疹的临床疗效。方法80例患者被随机分为治疗组48例和对照组32例,对照组口服氯雷他定、维乐生片、复方蒲公英片治疗,治疗组在此治疗的基础上应用美能注射液40 mL/d静脉滴注。结果治疗组总有效率为77.1%,对照组总有效率为53.1%,两组比较差异有显著性(P<0.05)。结论美能治疗玫瑰糠疹疗效较好,值得临床推广应用。

关 键 词:玫瑰糠疹  美能注射液  临床分析
文章编号:1006-8783(2006)01-0105-02
收稿时间:2005-11-21
修稿时间:2006-02-15

Observation of clinical efficacy of Stronger Neo-Minophagen C (SNMC) in the treatment of pityriasis rosea
WANG Ran,CAI Hong-wei,DONG Chen. Observation of clinical efficacy of Stronger Neo-Minophagen C (SNMC) in the treatment of pityriasis rosea[J]. Academic Journal of Guangdong College of Pharmacy, 2006, 22(1): 105-106
Authors:WANG Ran  CAI Hong-wei  DONG Chen
Affiliation:No. 5 Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong,519000, China
Abstract:
Objective To observe the clinical efficacy of SNMC(Stronger Neo-Minophagen C) in treatment of Pityriasis rosea.Methods Eighty patients were randomly divided into therapeutic and control groups.Tirty-two control patients were treated with Loratadine,compound Vitamine B,and Mongolian dandelion herb tablets.Another forty-eight patients were injected with SNMC(Stronger Neo-Minophagen C) 40ml/d based on the treatment of control groups.Results The general efficacy rate of therapeutic groups is 77.1%,whereas that in control groups is 53.1%(P<0.05).Conclusion SNMC(Stronger Neo-Minophagen C) presented a satisfying and reliable efficacy in the treatment of Pityriasis rosea.
Keywords:pityriasis rosea  SNMC(Stronger Neo-Minophagen C) injection
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号